Clinuvel Pharmaceuticals (ASX: CUV) – Managing Director Address 16 2026
Clinuvel Pharmaceuticals is starting a major transformation, committing to invest an average of A$55 million per annum over the next four years from...
Clinuvel Pharmaceuticals is starting a major transformation, committing to invest an average of A$55 million per annum over the next four years from...
Warburg Pincus has lifted its acquisition proposal for Ingenia Communities Group to $5.55 cash per stapled security, with an additional commitment...
Steadfast Group Limited has disclosed that it received a notice from Pentwater Capital Management LP relating to equity derivatives, filed under...
Peet Limited has executed the Flagstone JV Implementation Deed with Bechel Pty Ltd and Hurose Pty Ltd, marking a significant milestone in Ingenia...
Nine Entertainment delivered a strong financial result for FY26, with EBITDA up 17 percent and underlying earnings per share rising 11 percent, as...